Search - tctmd.com

Displaying 1 - 20 of 66

Sort: Relevancy | Date

Presentation THT 2025

Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension Group 2 (PreVail-PH2 Study)

Presenter: Marat Fudim

February 13, 2025

Presentation THT 2025

Pulmonary Artery Denervation for PH: Ready for Primetime?

Presenter: Greg Lewis

February 12, 2025

Presentation TCT 2024

TCT 466: Renal Artery Denervation Combined With Pulmonary Vein Isolation in Patients With Heart Failure and Atrial Fibrillation: A Randomized Trial Preliminary Results and Study Design

Presenter: Tomasz Skowerski

October 28, 2024

News Opinion Editor's Corner ACC 2024

What’s Going to Be Hot at ACC 2024

Shelley Wood

April 01, 2024

News Daily News

Biologic Winrevair Wins FDA Approval for Treatment of PAH

L.A. McKeown

March 27, 2024

Presentation THT 2024

Pulmonary Artery Denervation

Presenter: Alex M. K. Rothman

March 06, 2024

News Daily News

Top Endovascular News of 2023

L.A. McKeown

December 28, 2023

Presentation TCT 2023

TCT 3: Renal Artery Denervation Combined with Pulmonary Vein Isolation in Patients with Heart Failure and Atrial Fibrillation - Pilot Study

Presenter: Tomasz Skowerski

October 25, 2023

Presentation TCT 2023

Pulmonary Artery Denervation for Group II Pulmonary Hypertension: Updates from Ongoing Clinical Trials in China

Presenter: ShaoLiang Chen

October 23, 2023

News Opinion CV Team Dispatch

May 2023 News Roundup

L.A. McKeown

May 01, 2023

News Conference News THT 2023

Pulmonary Artery Denervation Makes Inroads in PAH Due to Left-Sided HF

Shelley Wood

March 21, 2023

Presentation THT 2023

Pulmonary Artery Denervation: Innovative Pulmonary Hypertension Therapies

Presenter: Gregg Stone

March 21, 2023

News Conference News TCT 2022

Pulmonary Artery Denervation in Idiopathic PAH Ups 6-Minute Walk Test

Shelley Wood

September 18, 2022

Presentation TCT 2022

Pulmonary Artery Denervation for Pulmonary Arterial Hypertension: A Sham-Controlled Randomised Trial

Presenter: ShaoLiang Chen

September 18, 2022

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Shelley Wood

September 07, 2022

Presentation TCT 2021

Outcomes of Pulmonary Artery Denervation for Treatment of PAH

Presenter: Gregg Stone

November 06, 2021

Presentation TCT 2019

Inter-Atrial Shunts for Pulmonary Hypertension (Group I and Group II)

Presenter: Daniel Burkhoff

September 27, 2019

Presentation TCT 2019

Aria: A Passive Device to Improve Pulmonary Compliance

Presenter: Irene Lang

September 27, 2019

Presentation TCT 2019

Pulmonary Artery Denervation II: Ultrasound-Based Therapy

Presenter: Alex Rothman

September 27, 2019

Presentation TCT 2019

Pulmonary Artery Denervation I: Radiofrequency Ablation

Presenter: Shao-Liang Chen

September 27, 2019

Advertisement

Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension Group 2 (PreVail-PH2 Study)

Pulmonary Artery Denervation for PH: Ready for Primetime?

TCT 466: Renal Artery Denervation Combined With Pulmonary Vein Isolation in Patients With Heart Failure and Atrial Fibrillation: A Randomized Trial Preliminary Results and Study Design

What’s Going to Be Hot at ACC 2024

Biologic Winrevair Wins FDA Approval for Treatment of PAH

Pulmonary Artery Denervation

Top Endovascular News of 2023

TCT 3: Renal Artery Denervation Combined with Pulmonary Vein Isolation in Patients with Heart Failure and Atrial Fibrillation - Pilot Study

Pulmonary Artery Denervation for Group II Pulmonary Hypertension: Updates from Ongoing Clinical Trials in China

May 2023 News Roundup

Pulmonary Artery Denervation Makes Inroads in PAH Due to Left-Sided HF

Pulmonary Artery Denervation: Innovative Pulmonary Hypertension Therapies

Pulmonary Artery Denervation in Idiopathic PAH Ups 6-Minute Walk Test

Pulmonary Artery Denervation for Pulmonary Arterial Hypertension: A Sham-Controlled Randomised Trial

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Outcomes of Pulmonary Artery Denervation for Treatment of PAH

Inter-Atrial Shunts for Pulmonary Hypertension (Group I and Group II)

Aria: A Passive Device to Improve Pulmonary Compliance

Pulmonary Artery Denervation II: Ultrasound-Based Therapy

Pulmonary Artery Denervation I: Radiofrequency Ablation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content